Cette année, restez connectés avec nous durant l’
ICPE All Access  et découvrez tous nos posters et présentations!

Présentation orale en cardiologie:

Effectiveness and Safety of Standard and Reduced Dose of Rivaroxaban Compared to Vitamin K Antagonists, According to Stroke and Bleeding Risk Score in Non- valvular Atrial Fibrillation, from a Hdps Matched Cohort within the Snds French Nationwide Claims (4411),



Face-to-face 3-year Comparative Effectiveness and Safety of Dabigatran and Rivaroxaban, Standard and Reduced Doses, for Nonvalvular Atrial Fibrillation: A Cohort Study in the French Nationwide Claims Database (PO-4733)


Survival Outcome in Patients with Metastatic Castration-resistant Prostate Cancer According to First-line Treatment (PO-3790)

Changes in Therapeutic Strategy in Metastatic Castration Resistant Prostate Cancer Between 2012 and 2014 from the French Nationwide Claims Database (PO-4343)

Methodological research:

Addressing Treatment Implementation Bias in the Construction of High Dimensional Propensity Scores (PO-2669)

Validation of an Algorithm Identifying Relapses in Multiple Sclerosis Using the French Nationwide Claims Database (PO-3874)

Empirical assessment of case-based methods for identification of drugs associated with upper gastrointestinal bleeding in the French National Healthcare System database (SNDS) (MY-PO02)

Effectiveness of treatment:

Effectiveness of Dimethylfumarate on Multiple Sclerosis, a French Cohort within SNDS Nationwide Claims Database (PO-3892)

Collaboration with RTI:

A Multinational European Study of Anaphylaxis Among Recipients of Intravenous Iron (PO-3835)

Feasibility of Studying the Use of Tissue- agnostic Cancer Drugs in Population- based European Health Databases (PO-4008),

Collaboration with a French team:

Factors Associated with Serious Vehicular Accidents: A Real-life Study (PO-4122).

En savoir plus sur l’ICPE All Access

En savoir plus sur les communications de la BPE  à l’ICPE 2020

La BPE à l’ICPE All Access les 16 et 17 Septembre 2020